Dementia is one of the greatest health and social care challenges of our time, affecting nearly 1 million people in the UK. With an ageing population, this number is expected to rise, making dementia research more critical than ever. In recent years, there have been positive strides in funding, but despite these efforts, dementia research still lags significantly behind other conditions such as cancer.
The Growing Burden of Dementia
Dementia is an umbrella term for a range of progressive neurological disorders, including Alzheimer’s disease, vascular dementia, and dementia with Lewy bodies. These conditions cause memory loss, cognitive decline, and, ultimately, a loss of independence, placing a heavy emotional and financial strain on individuals, families, and the health and social care system.
The cost of dementia to the UK economy is now estimated at £42 billion per year — a figure expected to rise to around £90 billion by 2040 as the number of people living with dementia grows from approximately 982,000 today to 1.4 million. Despite this economic impact, dementia research has historically been underfunded compared to other major health conditions.
How Dementia Research Funding Compares
Although dementia is the leading cause of death in the UK, research into the condition has long been overshadowed by other diseases, particularly cancer. In recent years, efforts have been made to redress this imbalance, but a significant funding gap remains.
In 2022/23, total government spend on dementia research was estimated at approximately £100 million, compared to £122 million through the NIHR alone for cancer — and that figure does not include the substantial additional funding cancer receives through charities such as Cancer Research UK. For every one dementia researcher in the UK, there are estimated to be four working on cancer.
The UK government pledged to double dementia research funding to £160 million per year by 2024/25, but that target has not consistently been met. Government spending on dementia research currently represents around 0.3% of the annual cost of the condition — compared to 1.6% for cancer.
This disparity is striking given that dementia is the UK’s biggest killer, claiming over 76,000 lives in 2024 alone. While cancer research has seen remarkable advances in treatment and survival rates, dementia remains the only one of the UK’s leading causes of death for which there are no treatments available on the NHS that can slow, stop, or prevent its progression.
Why Dementia Research Needs More Investment
There are several key reasons why increased funding for dementia research is crucial:
1. There Are No Effective Treatments
Unlike cancer, where early detection and advanced treatments have led to improved survival rates, dementia currently has no cure and no treatments that can halt or significantly slow its progression. Existing medications can only help manage symptoms for a limited time.
2. Dementia Research Has Historically Been Neglected
While conditions such as heart disease and cancer have benefitted from decades of substantial research investment, dementia funding only began to increase in the last decade. This historical underinvestment has delayed scientific progress.
3. The Social and Economic Impact Is Growing
Dementia is not just a health issue but a major social care challenge. Most people with dementia will require increasing levels of care, with many needing full-time residential support. Carers, often family members, provide an estimated £13.9 billion worth of unpaid care each year in the UK. Research into better treatments could reduce this burden.
4. Early Diagnosis and Prevention Need More Focus
Research into biomarkers, lifestyle interventions, and risk reduction has shown promise, but more funding is needed to develop tools that can identify dementia earlier and prevent its onset in high-risk individuals.
What Needs to Change?
To bridge the funding gap, dementia research needs:
- Sustained and increased investment from both government and private sector sources.
- Greater public awareness and advocacy to ensure dementia is prioritised in research funding decisions.
- A long-term commitment to dementia research, ensuring it receives the same level of focus as cancer and cardiovascular diseases.
- Support for innovative clinical trials to fast-track potential treatments.
The UK government has committed to doubling dementia research funding to £160 million per year, but it is crucial that this funding is delivered without delays and with a clear strategy for impact.
How You Can Help
While large-scale funding decisions are made at governmental and organisational levels, individuals can also play a role in supporting dementia research:
- Donate to dementia research charities, such as Alzheimer’s Research UK and the Alzheimer’s Society.
- Participate in research studies and trials, which are vital for advancing scientific understanding.
- Advocate for increased funding by engaging with MPs and raising awareness through social media.
Conclusion
The increase in dementia research funding in recent years is a step in the right direction, but it remains significantly behind other conditions such as cancer. Given the scale of the dementia crisis, further investment is urgently needed to drive breakthroughs in treatment, prevention, and care.
If we are to offer hope to the millions affected by dementia, we must continue to push for fair and sustainable research funding. Without it, we risk falling even further behind in the fight against this devastating condition.
Sources
- Alzheimer’s Research UK. “Dementia Statistics Hub.” https://www.alzheimersresearchuk.org
- Alzheimer’s Society. “The Cost of Dementia in the UK.” https://www.alzheimers.org.uk
- UK Government. “Dementia Research Funding Announcement (2019).” https://www.gov.uk
- Cancer Research UK. “Research Funding Overview.” https://www.cancerresearchuk.org
- Office for National Statistics. “Leading Causes of Death in the UK.” https://www.ons.gov.uk
In the Getting to Know Dementia programme we explore dementia as an umbrella term — looking at what different types have in common and how understanding progression can help us support people better. Find out more about the programme and upcoming dates.